Wegovy (semaglutide) is a brand-name weekly injectable prescription medication
When your doctor says you need 2.4 mg, that is the exact weight of the Semaglutide drug you need
Common side effects of GLP-1 agonists include gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain
No you should not accelerate the titration schedule without clinical guidance, as doing so significantly increases the risk of gastrointestinal side effects
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials